Virginia medical cannabis sales in January: What $15M Reveals

Virginia medical cannabis sales in January totaled about 15.08 million dollars, and that number matters to patients and markets. Because it reflects demand and supply, the figure gives early signals about price and access. Therefore we start with the headline number and then unpack what it means.

The state Cannabis Control Board published these data in a newly launched dashboard, which increases transparency. As a result, researchers and dispensary owners can compare trends month to month. MyCBDAdvisor uses a data driven and trustworthy approach to explain those trends for patients and industry readers.

In this article we break down product categories, transactions, grams packaged, and harvests. Additionally we highlight what the averages mean for patient costs and provider operations. Read on for clear charts, practical takeaways, and what this 15 million month signals for Virginia’s medical cannabis program. We start with the numbers and then give practical advice.

Virginia medical cannabis sales in January: trends and insights

The Virginia Cannabis Control Board dashboard reports total medical cannabis sales of about sixteen point zero eight million dollars in January. Because this figure tracks real purchases, it tells us about demand and supply. Therefore we examine the numbers and the likely drivers behind them.

Key trends and takeaways

• Sales level and stability. January sales came in at about fifteen point zero eight million dollars. However the figure sits close to prior months such as December at fifteen point six two million and October at fifteen point one five million. This suggests steady monthly demand.
• Product mix matters. Flower led with six point five five million dollars in sales. Concentrates followed with five point zero three million dollars. Edibles generated about two point five five million dollars. Shake and trim added nine hundred and twenty thousand dollars. As a result product assortment shapes revenue and inventory needs.
• Price and volume signals. The average price per gram of flower was ten dollars and twenty cents in January. There were one hundred twenty six thousand seven hundred six transactions, and one million two hundred sixteen thousand two hundred eighty seven grams packaged. Consequently per transaction spend and gram throughput reveal patient purchasing patterns.
• Supply chain indicators. Producers harvested seven thousand six hundred sixty nine medical cannabis plants in January. Total harvests reached fifty thousand six hundred twenty four since August two thousand twenty five. However grams packaged in January were lower than December and August, which points to inventory timing and processing cycles.

Context and practical notes

The data come directly from the state dashboard at Virginia Cannabis Control Board and were summarized in industry coverage at Ganjapreneur. For readers tracking regulation and market changes see MyCBDAdvisor analysis and guidance on the adult use bill at MyCBDAdvisor Adult Use Bill.

Virginia medical cannabis sales in January: month-by-month comparison

The table below compares monthly medical cannabis sales leading into January 2026. It highlights January sales for clarity and search relevance.

January sits within a narrow band near fifteen million dollars, signaling steady patient demand.

Virginia medical cannabis sales in January: Why $15.08M matters

Virginia medical cannabis sales in January totaled about $15.08 million and signal steady patient demand. Because the number records real purchases, it reveals trends in price, product mix, and supply. Therefore readers can use it to assess access and affordability.

Quick context

The state Cannabis Control Board released a new dashboard with month to month data. As a result transparency improved, and stakeholders can compare months. January sits near prior months in the fifteen million dollar range.

Why this matters to patients and markets

Flower led sales in January, while concentrates and edibles drove significant revenue. Additionally average price per gram and transaction counts show how patients buy. We will explain category breakdowns, grams packaged, harvest data, and practical takeaways. Read on for clear charts, data driven analysis, and concise recommendations from MyCBDAdvisor.

This introduction sets the stage for a data driven deep dive. We use state sourced figures and plain language. Expect actionable insights for patients, providers, and policymakers.

Virginia medical cannabis sales in January: detailed insights

January’s $15.08 million in Virginia medical cannabis sales gives an early look at demand and supply dynamics. Because the figure sits near recent months, it suggests steady patient purchasing rather than sharp growth. Therefore analysts and providers should watch category shifts instead of overall volume.

Top observations

• Product mix drove revenue. Flower led with $6.55 million, while concentrates reached $5.03 million. As a result flower and concentrates together made up most sales.
• Transactions and pricing. There were 126,706 transactions in January. Additionally the average price per gram was $10.20, which signals stable retail pricing for patients.
• Volume versus packaged grams. January packaged 1,216,287 grams. However this total fell from December and August volumes, which points to processing or inventory timing.
• Harvest and supply flow. Growers harvested 7,669 plants in January, with 50,624 plants harvested since August 2025. Consequently supply growth appears steady but variable month to month.
• Month to month context. January’s $15.08 million falls within a narrow band near $15 million. However December reached $15.62 million and September dipped to $13.83 million. Therefore volatility exists, but it has been limited.

Key factors influencing January sales

• Seasonality and patient renewal cycles likely affected buying patterns.
• Processing capacity and packaging throughput constrained grams packaged that month.
• Product assortment and inventory availability shaped per transaction spend.

For detailed source data see the Virginia Cannabis Control Board dashboard at Virginia Cannabis Control Board dashboard and industry coverage at Ganjapreneur coverage. For policy context and guidance, consult MyCBDAdvisor analysis and the adult use bill overview at MyCBDAdvisor adult use bill overview.

Virginia medical cannabis sales in January: month to month comparison

Key takeaways

• January sits near other months in the fifteen million dollar range, showing stable demand.
• Transactions data were available for January only, so average sale calculations are precise for that month.
• Use these figures to track per customer spending, throughput, and month to month performance.

Notes

Transactions for months before January were not provided in the state summary. Therefore their average sale per transaction cannot be calculated here.

Virginia medical cannabis sales in January: market trends and drivers

This section pulls key market signals from January data to show how demand, supply, and regulatory clarity are shaping Virginia medical cannabis and patient access.

Key market trends

• Product mix concentrates revenue. Flower accounted for roughly six point five five million dollars and concentrates about five point zero three million dollars, which means these two categories dominate sales and inventory planning.
• Pricing and customer behavior. January recorded one hundred twenty six thousand seven hundred six transactions and an average price near ten dollars twenty cents per gram, indicating steady per patient spend and retail pricing across dispensaries.
• Packaging and throughput constraints. Packaged grams fell to about one million two hundred sixteen thousand two hundred eighty seven grams, down from some prior months, which points to processing capacity and packaging cycles shaping monthly supply.
• Production and harvest cadence. Growers harvested seven thousand six hundred sixty nine plants in January and roughly fifty thousand six hundred twenty four since August twenty twenty five, showing growth in production but with monthly variability.
• Limited volatility but watch category shifts. Total sales sat near fifteen million dollars, so month to month swings are moderate, yet changes in product mix can alter revenue and access quickly.

Regulatory and policy impact

State transparency matters. The Virginia Cannabis Control Board dashboard provides primary source data at Virginia Cannabis Control Board Dashboard and industry context appears at Ganjapreneur. For ongoing guidance and policy analysis consult MyCBDAdvisor at MyCBDAdvisor.

In short, regulatory clarity and data transparency reduce uncertainty for providers and patients and directly influence how inventory, pricing, and access evolve.

Conclusion: Virginia medical cannabis sales in January — why it matters

January’s $15.08 million shows steady patient demand and stable market activity. Because the total aligns with recent months, it signals consistency rather than sharp growth. Flower and concentrates drove most revenue, while price per gram stayed near $10.20.

This stability matters to patients and businesses. Patients see predictable pricing and product availability. Businesses can plan inventory and staffing with more confidence. Additionally data partners and platforms such as Empe0 help researchers and operators monitor trends.

MyCBDAdvisor remains committed to clear, evidence based cannabinoid education and transparency. Therefore we use state data and industry reporting to explain what numbers mean for patients and policy. Visit MyCBDAdvisor for ongoing analysis and guides.

In short, January’s sales reinforce a steady medical cannabis market in Virginia. As a result stakeholders should track category shifts and packaging throughput. MyCBDAdvisor will keep reporting developments that affect patients and providers.

Frequently Asked Questions (FAQs)